SUBSCRIBE
SUBSCRIBE
News   Business

Alnylam Pharmaceuticals Reports First Quarter 2006 Financial Results

May 10, 2006 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 9, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, today reported its consolidated financial results for the quarter ended March 31, 2006 and company highlights.
Earnings
Alnylam Pharmaceuticals
MORE ON THIS TOPIC
Creative photo collage of funny young guy falling down shaming finger directing him stop corporate bullying isolated on pink background.
Layoffs
Rallybio Downsizes by 40% After Dropping Lead Asset
May 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Novavax/Getty Images, STR/NurPhoto
Earnings
Novavax Sales Jump 600% YoY as COVID-19 Vaccine Still in Limbo at FDA
May 8, 2025
 · 
3 min read
 · 
Heather McKenzie
Contemporary art collage. Businessman standing under heavy pressure. Working conditions. Concept of struggle, failure, success, competition, motivation, concentration, crisis, fear Copy space for ad
Cell therapy
Vor Bio Looks for Exit in Challenging Funding Environment; Lays Off 95% of Staff
May 8, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Illustration showing businessman avoiding potholes on way to goal
Job Trends
Job Market Woes: More Funding, Stability Needed for Turnaround
May 8, 2025
 · 
5 min read
 · 
Angela Gabriel